Ocular Therapeutix (OCUL) Successfully Appeals Patent Case Against Mati Therapeutics, Inc

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. AZN
9. SPCX
10. TRMD

Go back to Ocular Therapeutix (OCUL) Successfully Appeals Patent Case Against Mati Therapeutics, Inc
(NASDAQ: OCUL) Delayed: 9.94 -0.2 (1.97%)
Previous Close $10.14    52 Week High $14.50 
Open $10.15    52 Week Low $4.04 
Day High $10.26    P/E N/A 
Day Low $9.93    EPS $0.00 
Volume 1,355,538